Novel Rheumatoid Arthritis drugs succeed in the clinical trials: A status report by DelveInsight
18 mars 2021 21h30 HE
|
DelveInsight Business Research LLP
Los Angeles, USA , March 18, 2021 (GLOBE NEWSWIRE) -- Novel Rheumatoid Arthritis drugs succeed in the clinical trials: A status report by DelveInsight The Rheumatoid Arthritis Pipeline is robust as...
Exagen Inc. Reports Fourth Quarter and Full Year 2020 Results
16 mars 2021 16h05 HE
|
Exagen Inc.
SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full year...
Rheumatoid Arthritis Testing Market 2021 | Size, Share, Growth, Trends, Analysis, Revenue, Competitive Landscape, Forecast Report 2021-2028
12 mars 2021 04h44 HE
|
Fortune Business Insights
Pune, India, March 12, 2021 (GLOBE NEWSWIRE) -- The global rheumatoid arthritis testing market will derive growth from the high prevalence of the disease across the world. According to a report by...
SetPoint Medical CEO Murthy Simhambhatla Named to AIMBE College of Fellows
03 mars 2021 09h00 HE
|
SetPoint Medical
VALENCIA, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that the...
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 16, 2021
02 mars 2021 08h00 HE
|
Exagen Inc.
SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading autoimmune organization, will release financial results for the quarter and year ended December 31, 2020 after the...
Exagen Inc. to Participate in the Cowen 41st Annual Health Care Conference
22 févr. 2021 16h05 HE
|
Exagen Inc.
SAN DIEGO, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading autoimmune organization, today announced its participation in the Cowen 41st Annual Health Care Conference which...
WellDyne Partners with Scipher Medicine to Improve Patient Outcomes and Lower Costs for Rheumatoid Arthritis Care
11 févr. 2021 08h00 HE
|
Scipher Medicine Corporation
WALTHAM, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with their most effective therapy, today announced a partnership with WellDyne, a...
Exagen Inc. To Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
03 févr. 2021 16h05 HE
|
Exagen Inc.
SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading autoimmune organization, today announced its participation in the BTIG MedTech, Digital Health, Life Science &...
Scipher Medicine Brings Precision Medicine Platform to Patient-Centered MIT Initiative
03 févr. 2021 08h00 HE
|
Scipher Medicine Corporation
WALTHAM, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Scipher Medicine, a precision immunology company matching patients with the most effective therapy, announced today they have partnered with...
SetPoint Medical Announces First Patient Enrolled in the RESET-RA Study
01 févr. 2021 09h00 HE
|
SetPoint Medical
VALENCIA, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced the enrollment...